Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension

David G Warnock1, Stephen C Textor

  • 1Nephrology Research and Training Center, and Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35213, USA. dwarnock@uab.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|July 21, 2004
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term efficacy and safety of pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease: results from up to 5 years of the BRIGHT F51 phase III, open-label extension study.

Orphanet journal of rare diseases·2026
Same author

Impact of Proteinuria on Renal Outcomes in the BALANCE Trial.

Kidney international reports·2026
Same author

Recent Advances in Understanding the Pathophysiology of Fabry Disease.

Nephron·2025
Same author

Expanded View of the Pathophysiology of Fabry Disease.

Nephron·2025
Same author

A phase III, open-label clinical trial evaluating pegunigalsidase alfa administered every 4 weeks in adults with Fabry disease previously treated with other enzyme replacement therapies.

Journal of inherited metabolic disease·2024
Same author

Renovascular Disease and Mitochondrial Dysfunction in Human Mesenchymal Stem Cells.

Journal of the American Society of Nephrology : JASN·2024
Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Kidney Transplantation Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Multiple Myeloma.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Palliative Dialysis: Putting the Person First in Dialysis Care.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Metabolic Acidosis and Progression of CKD: Current Guidelines and Considerations.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same journal

Pathophysiology of Ketoacidosis: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
See all related articles